Full Text
The Full Text of this article is available as a PDF (68.2 KB).
References
- 1.Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005;5:558–567. doi: 10.1016/S1473-3099(05)70216-4. [DOI] [PubMed] [Google Scholar]
- 2.Asselah T, Marcellin P. New direct-acting antivirals' combination for the treatment of chronic hepatitis C. Liver Int. 2011;31(Suppl 1):68–77. doi: 10.1111/j.1478-3231.2010.02411.x. [DOI] [PubMed] [Google Scholar]
- 3.Ciesek S, von Hahn T, Colpitts CC. The green tea poly-phenol, epigallocatechin-3-gallate, inhibits hepatitis C virus entry. Hepatology. 2011;54:1947–1955. doi: 10.1002/hep.24610. [DOI] [PubMed] [Google Scholar]
- 4.Calland N, Albecka A, Belouzard S. (−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry. Hepatology. 2011 doi: 10.1002/hep.24803. [Epub ahead of print]. [DOI] [PubMed] [Google Scholar]
- 5.Suganuma M, Saha A, Fujiki H. New cancer treatment strategy using combination of green tea catechins and anticancer drugs. Cancer Sc/ 2011;102:317–323. doi: 10.1111/j.1349-7006.2010.01805.x. [DOI] [PubMed] [Google Scholar]
- 6.Timpe JM, Stamataki Z, Jennings A. Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies. Hepatology. 2008;47:17–24. doi: 10.1002/hep.21959. [DOI] [PubMed] [Google Scholar]
- 7.Maluf DG, Archer KJ, Villamil F, Stravitz RT, Mas V. Hepatitis C virus recurrence after liver transplantation: biomarkers of disease and fibrosis progression. Expert Rev Gastroenterol Hepatol. 2010;4:445–458. doi: 10.1586/egh.10.39. [DOI] [PubMed] [Google Scholar]
- 8.Marzano A. The prevention of viral recurrence in the long term. Dig Liver Dis. 2009;41(Suppl 2):S195–S197. doi: 10.1016/S1590-8658(09)60444-8. [DOI] [PubMed] [Google Scholar]
- 9.Bartosch B, Dubuisson J. Recent advances in Hepatitis C virus cell entry. Viruses. 2010;2:692–709. doi: 10.3390/v2030692. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Blanchard E, Belouzard S, Goueslain L. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol. 2006;80:6964–6972. doi: 10.1128/JVI.00024-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Wagoner J, Negash A, Kane OJ. Multiple effects of silymarin on the hepatitis C virus lifecycle. Hepatology. 2010;51:1912–1921. doi: 10.1002/hep.23587. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Chow HH, Cai Y, Hakim IA. Pharmacokinetics and safety of green tea polyphenols after multiple-dose administration of epigallocatechin gallate and polyphenon E in healthy individuals. Clin Cancer Res. 2003;9:3312–3319. [PubMed] [Google Scholar]